Delta-like ligand 3 (DLL3) is a novel target for molecular imaging of neuroendocrine prostate cancer Meeting Abstract


Authors: Korsen, J.; Kalidindi, T.; Khitrov, S.; Khuram, H.; Piorier, J.; Rudin, C.; Chen, Y.; Pillarsetty, N. V. K.; Lewis, J.
Abstract Title: Delta-like ligand 3 (DLL3) is a novel target for molecular imaging of neuroendocrine prostate cancer
Meeting Title: 2020 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI)
Journal Title: Journal of Nuclear Medicine
Volume: 61
Issue: Suppl. 1
Meeting Dates: 2020 Jun 12-15
Meeting Location: Virtual
ISSN: 0161-5505
Publisher: Society of Nuclear Medicine  
Date Published: 2020-05-01
Language: English
ACCESSION: WOS:000568290500120
PROVIDER: wos
Notes: Meeting Abstract: 133 -- Source: Wos